Chemoinformaics analysis of 2,4,6-Trimethyl-1,3,5-trithiane
| Molecular Weight | 180.363 | nRot | 0 |
| Heavy Atom Molecular Weight | 168.267 | nRig | 4 |
| Exact Molecular Weight | 180.01 | nRing | 1 |
| Solubility: LogS | -5.093 | nHRing | 1 |
| Solubility: LogP | 5.514 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 26.7215 |
| nHD | 0 | BPOL | 19.4185 |
| QED | 0.391 |
| Synth | 3.77 |
| Natural Product Likeliness | 2.956 |
| NR-PPAR-gamma | 0.797 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.011 |
| CACO-2 | -3.974 |
| MDCK | 0.0000297 |
| BBB | 0.023 |
| PPB | 1.00745 |
| VDSS | 1.557 |
| FU | 0.0116207 |
| CYP1A2-inh | 0.95 |
| CYP1A2-sub | 0.332 |
| CYP2c19-inh | 0.916 |
| CYP2c19-sub | 0.414 |
| CYP2c9-inh | 0.888 |
| CYP2c9-sub | 0.987 |
| CYP2d6-inh | 0.091 |
| CYP2d6-sub | 0.446 |
| CYP3a4-inh | 0.819 |
| CYP3a4-sub | 0.104 |
| CL | 6.165 |
| T12 | 0.103 |
| hERG | 0 |
| Ames | 0.517 |
| ROA | 0.902 |
| SkinSen | 0.948 |
| Carcinogencity | 0.75 |
| EI | 0.987 |
| Respiratory | 0.95 |
| NR-Aromatase | 0.891 |
| Antiviral | No |
| Prediction | 0.955128 |